Health Care/Hospital

I-Mab to Participate at the Jefferies Global Healthcare Conference

ROCKVILLE, Md., May 22, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the ...

2024-05-22 19:00 1402

Waterdrop Inc. to Report First Quarter 2024 Financial Results on June 5, 2024

BEIJING, May 22, 2024 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH ) ("Waterdrop" or the "Company"), a leading technology platform de...

2024-05-22 18:00 3008

Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024

New report highlights innovations poised to drive significant clinical and market impact LONDON, May 22, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of theMedical Technologies to Watch in 2024 report. This ...

2024-05-22 15:00 1761

GCCL Leverages ddPCR to Enhance Gene/cell Therapy Clinical Trial Services

* Introduced the first ddPCR device in Korea to provide high-quality clinical trial sample analysis services by increasing test accuracy * Differentiate global lab services for cell and gene therapy clinical trials with cutting-edge technology YONGIN, South Korea, May 22, 2024 /PRNewswire/ -- ...

2024-05-22 13:00 1685

Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of HER3/TROP2 Bispecific ADC Drug JSKN016

SUZHOU, China, May 22, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the phase I clinical study (JSKN016-101) of JSKN016, a novel bispecific antibody-drug conjugate (ADC) targeting HER3 and TROP2, in the treatment of ...

2024-05-22 09:16 2046

Equitable access to treatment must keep pace with latest advances in reproductive surgery

MANILA, Philippines, May 22, 2024 /PRNewswire/ -- Profound benefits of new developments in reproductive surgery that facilitate parenthood and enhance quality of life will only be fully realised by making them accessible to all people experiencing the distress of infertility. The challenge lie...

2024-05-22 09:00 1853

Advanced Waste Management Solution for Hospitals

SYDNEY, May 22, 2024 /PRNewswire/ -- Smart waste management in hospitals has been increasingly important for achieving the higher standards of safety and environmental expectation required by patients and staff compared with other sectors. (Sourc...

2024-05-22 07:00 2171

YS Biopharma Announces Results of Extraordinary General Meeting

GAITHERSBURG, Md., May 22, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseas...

2024-05-22 04:15 3117

Announcement of The Shaw Laureates 2024

HONG KONG, May 21, 2024 /PRNewswire/ -- 2024 Shaw Laureates (Left to Right): Shrinivas R Kulkarni (Astronomy), Swee Lay Thein (Life Science and Medicine), Stuart Orkin (Life Science and Medi...

2024-05-21 21:58 2678

Oncology Events in Poland Solidify Collaboration with NCCN

The National Comprehensive Cancer Network participates in meetings hosted by Maria Sklodowska-Curie National Research Institute of Oncology, the Polish Oncological Society, and Alliance for Innovation to advance work adapting proven cancer treatment guidelines forPoland. WARSAW, Poland, May 21, ...

2024-05-21 21:03 1534

Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston's Biotech Hub

The laboratory gives researchers a training ground for state-of-the-art DNBSEQ technology to further precision diagnostics and treatments SAN JOSE, Calif., May 21, 2024 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced theMay 22 opening of its Customer E...

2024-05-21 21:00 1726

New CAS BioFinder Discovery Platform empowers drug discovery scientists to reveal insights, drive innovation, and save time

Transformative new scientific information capabilities combine an unparalleled collection of curated science data with advanced predictive models to accelerate early-stage drug discovery innovation COLUMBUS, Ohio, May 21, 2024 /PRNewswire/ -- Today, CAS, a division of the American Chemical Socie...

2024-05-21 21:00 2230

Etiometry Awarded Frost & Sullivan's 2024 North American Enabling Technology Leadership Award for Leading Innovation in Clinical Decision Support Systems

Etiometry's solutions provide healthcare professionals with actionable intelligence, setting new benchmarks in critical care treatment. SAN ANTONIO, May 21, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the clinical decision support for critical care industry and, based on its findin...

2024-05-21 20:00 1478

Ractigen Therapeutics Secures FDA Fast Track Designation for RAG-01, a First-in-Class saRNA Therapy

SUZHOU, China, May 21, 2024 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, proudly announces that its flagship program, RAG-01, has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA). This notable a...

2024-05-21 20:00 1676

Cali Biosciences Announces Publication of Successful Phase 2 Study Results in Hernia

SAN DIEGO, May 21, 2024 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali Biosciences"), a biotechnology company dedicated to the research and development of innovative drugs, announced publication of "CPL‑01, an investigational long‑acting ropivacaine, demonstrates saf...

2024-05-21 17:52 1075

RemeGen Completes Patient Enrollment in Two Phase III Clinical Trials Using Telitacicept for Treatment of IgA Nephropathy and Primary Sjögren's Syndrome

YANTAI, China, May 21, 2024 /PRNewswire/ -- RemeGen Co. Ltd.  ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently announced significant progress of Telitacicept (RC18), that two Phase III clinical trials inChina for the t...

2024-05-21 17:35 1754

So-Young to Report First Quarter 2024 Financial Results on May 28, 2024

BEIJING, May 21, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financ...

2024-05-21 17:00 2040

Dignitana signs an exclusivity agreement for Japan with Konica Minolta

LUND, Sweden, May 21, 2024 /PRNewswire/ -- Dignitana has signed a new multi-year Distribution Agreement for technology market leaderKonica Minolta to be the exclusive provider of The DigniCap Scalp Cooling System inJapan. DigniCap Delta is an innovative medical device used by cancer centers to m...

2024-05-21 16:43 1347

BGI Team Successfully Reaches the Summit of Mount Everest

Sends the world's first ultrasound image and EEG data from the top of the world SHENZHEN, China, May 21, 2024 /PRNewswire/ -- BGI Group Chairman and Co-Founder,Wang Jian, and a scientific team from BGI today reached the summit of Mount Everest (Qomolangma) at 8,848.86 meters and, using handheld u...

2024-05-21 16:41 1574

NUS scientists discover a novel way of activating muscle cells' natural defences against cancer using magnetic pulses

This drug-free, non-invasive approach could open the doors for new developments in cancer therapy and cancer biomarker discovery SINGAPORE, May 21, 2024 /PRNewswire/ -- A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovation & Technolo...

2024-05-21 16:35 1521
1 ... 85868788899091 ... 847

Week's Top Stories